Detailansicht

Wissensnetz

Person

Nina Ditsch (1974-)

Name	Nina Ditsch
Zeit	1974- (Lebensdaten)
Ort	Deutschland
Akademischer Grad bzw. Titel	Dr. med. (Medizinische Fakultät)
Variante	Nina Caroline Ditsch N. Ditsch
Datensatztyp	Person
GND-Nummer	124456944
Datensatz-ID	124456944
Beteiligt an alle anzeigen Discussion of ABC7 Consensus and German Recommendations Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024 ABC7 Consensus: Assessment by a German Group of Experts Atlas der Brustchirurgie : Operationstechniken Step by Step Atlas der Brustchirurgie : Operationstechniken Step by Step Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer The expression of TIM-3 and Gal-9 on macrophages and Hofbauer cells in the placenta of preeclampsia patients Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey Cytoplasmic localization of thyroid hormone receptor (TR) alpha and nuclear expression of its isoform TRα2 determine survival in breast cancer in opposite ways Elderly and patients with large breast volume have an increased risk of seroma formation after mastectomy — results of the SerMa pilot study Real de-escalation or escalation in disguise? Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer: controversies and standards in healthcare Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery Uncertainties and controversies in axillary management of patients with breast cancer Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022 Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer 259 (PB-083) Poster - Cytokine identification in seroma fluid after mastectomy in breast cancer patients – first results of SerMa pilot study subgroup [Abstract] Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey Prognostic relevance of nuclear receptors in relation to peritumoral inflammation and tumor infiltration by lymphocytes in breast cancer The role of E-Cadherin expression in primary site of breast cancer Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs) Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany - a retrospective cohort study Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer The prognostic impact of retinoid X receptor and thyroid hormone receptor alpha in unifocal vs. multifocal/multicentric breast cancer The role of E-Cadherin expression in primary site of breast cancer Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs) Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019 Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany : : a multicenter feasibility and acceptance survey Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: a multicenter feasibility and acceptance survey Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer L-Dopa-Decarboxylase (DDC) is a positive prognosticator for breast cancer patients and epinephrine regulates breast cancer cell (MCF7 and T47D) growth in vitro according to their different expression of Gi-protein-coupled receptors TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials AGO recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2019 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019 EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer The prognostic impact of the Aryl Hydrocarbon Receptor (AhR) in primary breast cancer depends on the lymph node status THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Nina Ditsch (1974-)

Discussion of ABC7 Consensus and German Recommendations

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

ABC7 Consensus: Assessment by a German Group of Experts

Atlas der Brustchirurgie : Operationstechniken Step by Step

Atlas der Brustchirurgie : Operationstechniken Step by Step

Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer

The expression of TIM-3 and Gal-9 on macrophages and Hofbauer cells in the placenta of preeclampsia patients

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery

Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare

Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey

Cytoplasmic localization of thyroid hormone receptor (TR) alpha and nuclear expression of its isoform TRα2 determine survival in breast cancer in opposite ways

Elderly and patients with large breast volume have an increased risk of seroma formation after mastectomy — results of the SerMa pilot study

Real de-escalation or escalation in disguise?

Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare

Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer: controversies and standards in healthcare

Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery

Uncertainties and controversies in axillary management of patients with breast cancer

Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

259 (PB-083) Poster - Cytokine identification in seroma fluid after mastectomy in breast cancer patients – first results of SerMa pilot study subgroup [Abstract]

Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey

Prognostic relevance of nuclear receptors in relation to peritumoral inflammation and tumor infiltration by lymphocytes in breast cancer

The role of E-Cadherin expression in primary site of breast cancer

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany - a retrospective cohort study

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

The prognostic impact of retinoid X receptor and thyroid hormone receptor alpha in unifocal vs. multifocal/multicentric breast cancer

The role of E-Cadherin expression in primary site of breast cancer

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)

Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019

Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany : : a multicenter feasibility and acceptance survey

Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: a multicenter feasibility and acceptance survey

Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer

L-Dopa-Decarboxylase (DDC) is a positive prognosticator for breast cancer patients and epinephrine regulates breast cancer cell (MCF7 and T47D) growth in vitro according to their different expression of Gi-protein-coupled receptors

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge

Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer

Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2019

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019

EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification

Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials

Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

The prognostic impact of the Aryl Hydrocarbon Receptor (AhR) in primary breast cancer depends on the lymph node status

THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration